SCHEMBL9157699

SCHEMBL9157699

O=c1ccn([C@@H]2O[C@H](C(O)C(c3ccccc3)(c3ccccc3)c3ccccc3)[C@@H](O)[C@H]2O)c(=O)[nH]1

nearest known ligand 0.53

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
SLC28A1 O00337 1/20 0.53
SLC28A2 O43868 1/20 0.53
SLC29A1 Q99808 1/20 0.53
SLC28A3 Q9HAS3 1/20 0.53
P2RY2 P41231 5/20 0.47
P2RY6 Q15077 4/20 0.45
P2RY14 Q15391 1/20 0.45
DUT P33316 2/20 0.44
P2RY4 P51582 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL442715 0.91 P2RY14 (0.48) SLC28A1SLC28A2SLC29A1SLC28A3P2RY2
SCHEMBL442714 0.88 SLC28A1 (0.43) SLC28A1SLC28A2SLC29A1SLC28A3P2RY2
SCHEMBL27741782 0.84 SLC28A1 (0.56) SLC28A1SLC28A2SLC29A1SLC28A3P2RY2
SCHEMBL7524816 0.84 SLC28A1 (0.47) SLC28A1SLC28A2SLC29A1SLC28A3P2RY2
SCHEMBL8970268 0.84 P2RY14 (0.46) SLC28A1SLC28A2SLC29A1SLC28A3P2RY2
SCHEMBL8538694 0.84 P2RY14 (0.44) SLC28A1SLC28A2SLC29A1SLC28A3P2RY2
SCHEMBL6832098 0.84 P2RY14 (0.44) SLC28A1SLC28A2SLC29A1SLC28A3P2RY2
SCHEMBL8210384 0.84 P2RY14 (0.44) SLC28A1SLC28A2SLC29A1SLC28A3P2RY2
SCHEMBL154356 0.83 SLC28A1 (0.60) SLC28A1SLC28A2SLC29A1SLC28A3P2RY2
SCHEMBL29891224 0.83 SLC28A1 (0.38) SLC28A1SLC28A2SLC29A1SLC28A3P2RY2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0378706-B1 5-SUBSTITUTED URIDINE DERIVATIVES AND INTERMEDIATES FOR THEIR PREPARATION TAIHO PHARMACEUTICAL CO LTD (JP) 1994-12-28 EP claimed
US-5470967-A Hybridization probes to detect nucleic acid sequences THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1995-11-28 US disclosed
EP-0517796-B1 OLIGONUCLEOTIDE ANALOGS DU PONT MERCK PHARMA (US) 1995-04-19 EP disclosed